Targeting the mevalonate pathway in multiple myeloma

被引:3
|
作者
van der Spek, Ellen [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Hematol, NL-3584 CX Utrecht, Netherlands
关键词
Multiple myeloma; Mevalonate pathway; Plasma cell lines; FPP; GGPP; CELL-LINES; DRUG-RESISTANCE; PLASMA-CELLS; APOPTOSIS; SIMVASTATIN; INHIBITOR; SURVIVAL; PROTEIN; GERANYLGERANYLATION; FARNESYLATION;
D O I
10.1016/j.leukres.2009.07.027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:267 / 268
页数:2
相关论文
共 50 条
  • [21] Anti-cancer therapy: Targeting the mevalonate pathway
    Swanson, KM
    Hohl, RJ
    CURRENT CANCER DRUG TARGETS, 2006, 6 (01) : 15 - 37
  • [22] Drug repositioning for ovarian cancer targeting mevalonate pathway
    Kobayashi, Y.
    Kunitomi, H.
    Banno, K.
    Nagai, S.
    Anko, M.
    Takahashi, T.
    Iijima, M.
    Takeda, T.
    Watanabe, K.
    Matoba, Y.
    Nakamura, K.
    Tsuji, K.
    Tominaga, E.
    Tanaka, M.
    Aoki, D.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 82 - 82
  • [23] Inhibiting prostate cancer by targeting the metabolic mevalonate pathway
    dos Santos, Diandra Zipinotti
    Elbaz, Mohamad
    Branchard, Emily
    Schormann, Wiebke
    Andrews, David W.
    Penn, Linda Z.
    CANCER RESEARCH, 2023, 83 (11)
  • [24] Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins
    Iannelli, Federica
    Lombardi, Rita
    Milone, Maria R.
    Pucci, Biagio
    De Rienzo, Simona
    Budillon, Alfredo
    Bruzzese, Francesca
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2018, 13 (02) : 184 - 200
  • [26] MULTIPLE MYELOMA-ASSOCIATED DRUG RESISTANCE: TARGETING THE NOTCH PATHWAY
    Garavelli, S.
    Lazzari, E.
    Colombo, M.
    Paoli, A.
    Moschini, A.
    Platonova, N.
    Galletti, S.
    Todoerti, K.
    Neri, A.
    Chiaramonte, R.
    HAEMATOLOGICA, 2015, 100 : 159 - 159
  • [27] Targeting Extracellular Vesicles in Multiple Myeloma: A New Role for the Notch Pathway
    Giannandrea, D.
    Colombo, M.
    Platonova, N.
    Mazzola, M.
    Baccianti, F.
    Adami, R.
    Cantone, L.
    Milano, E.
    Velluti, C.
    Pistocchi, A.
    Bollati, V.
    Ancona, S.
    Lesma, E.
    Turrini, M.
    Chiaramonte, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (05): : S31 - S32
  • [28] Targeting the vascular endothelial growth factor pathway in the treatment of multiple myeloma
    Podar, Klous
    Richardson, Poul G.
    Chauhan, Dharminder
    Anderson, Kenneth C.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (04) : 551 - 566
  • [29] Targeting the mevalonate biosynthesis pathway in gemcitabine resistant pancreatic cancer
    Beutel, Alica K.
    Calderon, Sabrina
    Nghiem, Ethan
    Singh, Rima
    Anaraki, Cecily
    Gulay, Kevin
    Tiriac, Herve
    Kleger, Alexander
    Seufferlein, Thomas
    Muir, Alexander
    Jang, Cholsoon
    Juarez, Dennis
    Fruman, David
    Halbrook, Christopher
    CANCER RESEARCH, 2024, 84 (02)
  • [30] Targeting mutant p53 through the mevalonate pathway
    Freed-Pastor, William
    Prives, Carol
    NATURE CELL BIOLOGY, 2016, 18 (11) : 1122 - 1124